Annual Drug Patent Expirations for ACCUNEB
Accuneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ACCUNEB.
This drug has twelve patent family members in eight countries.
The generic ingredient in ACCUNEB is albuterol sulfate. One supplier is listed for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
